688373 盟科藥業
按盤價 
4.860 +0.570 (+13.287%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -27.046 | -41.120 | -26.660 | -42.749 | -30.320 |
| 總資產報酬率 ROA (%) | -18.541 | -31.593 | -20.532 | -34.349 | -23.403 |
| 投入資產回報率 ROIC (%) | -20.341 | -33.692 | -21.557 | -37.106 | -26.955 | 邊際利潤分析 |
| 銷售毛利率 (%) | 81.510 | 81.608 | 81.699 | 92.449 | -- |
| 營業利潤率 (%) | -323.587 | -452.655 | -462.460 | -3,343.976 | -- |
| 息稅前利潤/營業總收入 (%) | -313.575 | -448.462 | -435.981 | -2,911.436 | -- |
| 淨利潤/營業總收入 (%) | -331.429 | -463.914 | -456.987 | -2,953.915 | -- | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.212 | 107.841 | 121.401 | 120.365 | 112.284 |
| 價值變動淨收益/利潤總額(%) | -5.053 | -8.032 | -8.394 | -4.654 | 0.163 |
| 營業外收支淨額/利潤總額(%) | 0.003 | 1.024 | -1.200 | -13.224 | -12.172 | 償債能力分析 |
| 流動比率 (X) | 8.268 | 7.715 | 11.906 | 5.410 | 19.930 |
| 速動比率 (X) | 7.875 | 7.441 | 11.716 | 5.293 | 19.761 |
| 資產負債率 (%) | 34.723 | 28.630 | 18.906 | 32.406 | 7.283 |
| 帶息債務/全部投入資本 (%) | 20.723 | 13.112 | 9.154 | 7.511 | -2.499 |
| 股東權益/帶息債務 (%) | 341.906 | 602.728 | 918.363 | 973.704 | -4,001.456 |
| 股東權益/負債合計 (%) | 187.991 | 249.282 | 428.927 | 208.583 | 1,273.134 |
| 利息保障倍數 (X) | -31.291 | -50.535 | -20.766 | -69.367 | -58.129 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.763 | 65.595 | 46.745 | 66.585 | -- |
| 存貨周轉天數 (天) | 641.987 | 640.488 | 671.209 | 5,171.330 | -- |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
